Wilmington, Delaware–(Newsfile Corp. – April 18, 2022) – Rigrodsky Law, P.A. is investigating Antares Pharma, Inc. (“Antares”) (NASDAQ: ATRS) regarding possible breaches of fiduciary duties and other violations of law related to Antares’ agreement to be acquired by Halozyme Therapeutics, Inc. (NASDAQ: HALO). Under the terms of the agreement, Antares’ shareholders will receive $5.60 in cash for each share of Antares common stock they own.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-antares-pharma-inc.
To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email [email protected].
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/120747
